What data says about Tukaram Mundhe’s 100-day stint as FDA Commissioner
Data released on Tukaram Mundhe’s first 100 days as Food and Drug Administration chief shows a sharp rise in enforcement activity. Compared with the same period in 2025‑26, complaints to the agency rose by 557%, investigations of those complaints increased 378%, and searches and seizures grew 217%. The figures, drawn from FDA records, indicate a significant uptick in regulatory actions under Mundhe’s leadership.